Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.12)
# 1,004
Out of 5,178 analysts
893
Total ratings
39.73%
Success rate
1.79%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAR Pharming Group | Reiterates: Buy | $37 | $16.17 | +128.89% | 18 | Mar 24, 2026 | |
| LCTX Lineage Cell Therapeutics | Reiterates: Buy | $9 | $1.52 | +492.11% | 14 | Mar 24, 2026 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $6 | $1.63 | +269.23% | 25 | Mar 23, 2026 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $33.24 | +206.86% | 36 | Mar 23, 2026 | |
| XOMA XOMA Royalty | Reiterates: Buy | $97 | $30.82 | +214.73% | 26 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $60 | $29.48 | +103.53% | 29 | Mar 13, 2026 | |
| PHGE BiomX | Downgrades: Neutral | n/a | $4.94 | - | 19 | Mar 9, 2026 | |
| QTTB Q32 Bio | Initiates: Buy | $13 | $7.67 | +69.49% | 1 | Feb 25, 2026 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $231 → $239 | $206.63 | +15.67% | 23 | Feb 24, 2026 | |
| FBIO Fortress Biotech | Reiterates: Buy | $17 | $2.84 | +498.59% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $15 | $8.76 | +71.23% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $16 | $6.98 | +129.23% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.68 | +489.54% | 16 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.60 | - | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $1.70 | +548.97% | 20 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.48 | +371.98% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 → $310 | $255.25 | +21.45% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $63.05 | +115.70% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.73 | +593.64% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.69 | +337.89% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $4.47 | +56.62% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.47 | +1,606.48% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $6.51 | -7.76% | 19 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $28.04 | +67.62% | 6 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $0.62 | +2,335.46% | 33 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $3.77 | +139.04% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $31.07 | +67.36% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $26.39 | +115.99% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.20 | +1,983.33% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.76 | +479.71% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.80 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.02 | +199.10% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $32.31 | +29.99% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $29.46 | +1.82% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $7.79 | +28.37% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.62 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $31.90 | +31.66% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.32 | +961.01% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.04 | +284.62% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.44 | +3,998.36% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.86 | +109.79% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.40 | +983.33% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.35 | +11,814.89% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.62 | +2,623.49% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $5.70 | +461.31% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.17 | +5,205.04% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.31 | +1,274.05% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $5.48 | +337.96% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.94 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $5.51 | +462.61% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.59 | +1,951.28% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.61 | +583.23% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $21.13 | -66.86% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.75 | +3,238.23% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.76 | +13,143.28% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.55 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.14 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $31.50 | +4.76% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $5.30 | +1,371.70% | 1 | Mar 24, 2017 |
Pharming Group
Mar 24, 2026
Reiterates: Buy
Price Target: $37
Current: $16.17
Upside: +128.89%
Lineage Cell Therapeutics
Mar 24, 2026
Reiterates: Buy
Price Target: $9
Current: $1.52
Upside: +492.11%
Lexicon Pharmaceuticals
Mar 23, 2026
Reiterates: Buy
Price Target: $6
Current: $1.63
Upside: +269.23%
Viking Therapeutics
Mar 23, 2026
Reiterates: Buy
Price Target: $102
Current: $33.24
Upside: +206.86%
XOMA Royalty
Mar 20, 2026
Reiterates: Buy
Price Target: $97
Current: $30.82
Upside: +214.73%
Capricor Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $60
Current: $29.48
Upside: +103.53%
BiomX
Mar 9, 2026
Downgrades: Neutral
Price Target: n/a
Current: $4.94
Upside: -
Q32 Bio
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $7.67
Upside: +69.49%
Ligand Pharmaceuticals
Feb 24, 2026
Maintains: Buy
Price Target: $231 → $239
Current: $206.63
Upside: +15.67%
Fortress Biotech
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $2.84
Upside: +498.59%
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $8.76
Upside: +71.23%
Feb 13, 2026
Upgrades: Buy
Price Target: $16
Current: $6.98
Upside: +129.23%
Jan 29, 2026
Maintains: Buy
Price Target: $5 → $4
Current: $0.68
Upside: +489.54%
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.60
Upside: -
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $1.70
Upside: +548.97%
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.48
Upside: +371.98%
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $255.25
Upside: +21.45%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $63.05
Upside: +115.70%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $1.73
Upside: +593.64%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.69
Upside: +337.89%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $4.47
Upside: +56.62%
Dec 2, 2025
Reiterates: Buy
Price Target: $8
Current: $0.47
Upside: +1,606.48%
Dec 1, 2025
Upgrades: Buy
Price Target: $6
Current: $6.51
Upside: -7.76%
Nov 28, 2025
Reiterates: Buy
Price Target: $47
Current: $28.04
Upside: +67.62%
Nov 13, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $0.62
Upside: +2,335.46%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $3.77
Upside: +139.04%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $31.07
Upside: +67.36%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $26.39
Upside: +115.99%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.20
Upside: +1,983.33%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.76
Upside: +479.71%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.80
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $5.02
Upside: +199.10%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $32.31
Upside: +29.99%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $29.46
Upside: +1.82%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $7.79
Upside: +28.37%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $31.90
Upside: +31.66%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.32
Upside: +961.01%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.04
Upside: +284.62%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.44
Upside: +3,998.36%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.86
Upside: +109.79%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.40
Upside: +983.33%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.35
Upside: +11,814.89%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $0.62
Upside: +2,623.49%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $5.70
Upside: +461.31%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.17
Upside: +5,205.04%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.31
Upside: +1,274.05%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $5.48
Upside: +337.96%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.94
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $5.51
Upside: +462.61%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.59
Upside: +1,951.28%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.61
Upside: +583.23%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $21.13
Upside: -66.86%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.75
Upside: +3,238.23%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.76
Upside: +13,143.28%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.55
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.14
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $31.50
Upside: +4.76%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $5.30
Upside: +1,371.70%